Paul Ehrlich's Magic Bullets
Published March 11, 2004
N Engl J Med 2004;350:1079-1080
DOI: 10.1056/NEJMp048021
Abstract
March 14, 2004, marks the 150th anniversary of the birth of Paul Ehrlich, one of the generation of pioneers who, during the 50 years that led up to World War I, laid the foundation of modern medicine. Pasteur, Röntgen, Curie, Koch, Freud, and Lister were his contemporaries in this company of trailblazers.
Ehrlich's prodigious talents in the laboratory — he was called a virtuoso of test tubes — were matched by a combination of intuition and deduction that marked him as a genius. He was the father of hematology, a revolutionary immunologist, and the creator of the field of chemotherapy. . . .
Information & Authors
Information
Published In
Copyright
Copyright © 2004 Massachusetts Medical Society. All rights reserved.
For personal use only. Any commercial reuse of NEJM Group content requires permission.
History
Published online: March 11, 2004
Published in issue: March 11, 2004
Topics
Authors
Metrics & Citations
Metrics
Altmetrics
Citations
Export citation
Select the format you want to export the citation of this publication.
Cited by
- Biomaterials in personalized drug delivery: innovations, challenges, and future directions, PeerJ, 14, (e20982), (2026).https://doi.org/10.7717/peerj.20982
- The evolving landscape of antibody-based cancer therapies: From monospecific to multi-specific and beyond, Critical Reviews in Oncology/Hematology, 217, (105037), (2026).https://doi.org/10.1016/j.critrevonc.2025.105037
- Recent clinical advances in nonconjugated antibodies and antibody-drug conjugates for colorectal cancer treatment, Cancer Cell International, 25, 1, (2025).https://doi.org/10.1186/s12935-025-04039-8
- Development of antibody drug conjugates targeting epithelial membrane protein 2-highly expressed lung cancer, Cell Death & Disease, 16, 1, (2025).https://doi.org/10.1038/s41419-025-08125-7
- Advancements in antibody-drug conjugates as cancer therapeutics, Journal of the National Cancer Center, 5, 4, (362-378), (2025).https://doi.org/10.1016/j.jncc.2025.01.007
- Linker Design for the Antibody Drug Conjugates: A Comprehensive Review, ChemMedChem, 20, 15, (2025).https://doi.org/10.1002/cmdc.202500262
- Multifunctional nanoparticle platform for targeted delivery and vaccines, iScience, 28, 6, (112599), (2025).https://doi.org/10.1016/j.isci.2025.112599
- Advances in cancer immunotherapy: historical perspectives, current developments, and future directions, Molecular Cancer, 24, 1, (2025).https://doi.org/10.1186/s12943-025-02305-x
- Exploring immunotherapy with antibody-drug conjugates in solid tumor oncology, Immunotherapy: Magic Bullet to Change the Future Therapeutics, (259-286), (2025).https://doi.org/10.1016/bs.apcsb.2024.10.016
- Antibody drug conjugates integrated with lipid nanocarrier for cancer theranostics, Lipid-Drug Conjugates, (333-363), (2025).https://doi.org/10.1016/B978-0-443-33382-8.00012-1
- See more
Loading...